Mir-130b and mir-125b in hepatocellular carcinoma patients process: submission:02/11/2022 acceptance:08/13/2022 clinical significance of mir-130b and mir-125b as biomarkers in hepatocellular carcinoma

HIGHLIGHTS

• who: Asian Pac J Cancer et al. from the This study was conducted in the Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, and Internal Medicine Department of the National Liver Institute, Menoufia University, and this study included , subjects collected from April , to December They were distributed into three groups: the control group included , age- and sex frequency matched healthy blood donors have published the article: MiR-130b and MiR-125b in Hepatocellular Carcinoma Patients Process: Submission:02/11/2022 Acceptance:08/13/2022 Clinical Significance of MiR-130b and MiR-125b as Biomarkers . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.